Low PMCA4b expression was found in the luminal subtype and HER2 overexpressing cells, whereas the triple negative, basal cancer cells, representing a more aggressive breast cancer subtype showed high PMCA4b and PMCA1 expression levels. This evidence concerns the gene ATP2B1 and breast cancer.